Raymond James & Associates Amarin Corp Plcuk Call Options Transaction History

Raymond James & Associates

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2019 Nov 07, 2019	SELL	$13.89 - $23.16 $144,456 - $240,864	-10,400 Reduced 41.6%	14,600 $31,000
Q2 2019 Aug 06, 2019	BUY	$16.27 - $20.51 $165,954 - $209,202	10,200 Added 68.92%	25,000 $46,000
Q1 2019 May 06, 2019	SELL	$12.61 - $22.33 $94,575 - $167,475	-7,500 Reduced 33.63%	14,800 $51,000
Q3 2018 Nov 14, 2018	BUY	$2.45 - $16.27 $54,635 - $362,821	22,300 New	22,300 $1,000

181

68.6M

192K

78.1K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $246M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.